TG Therapeutics (TGTX) Misses Q2 EPS by 8c

TG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Canaan Inc. (CAN) PT Lowered to $2 at BTIG
• Casey's General Stores (CASY) Tops Q1 EPS by 69c